Anticoagulation in NVAF and VTE: Risk Prediction Scores With Renal Criteria

Launch Date

12/22/2023

Credit Amount

0.00 Resources

Credit Expires

This activity is part of a series

When implementing anticoagulants to prevent thrombotic events (eg, stroke, pulmonary embolism, deep vein thrombosis) in non-valvular atrial fibrillation (NVAF) and/or venous thromboembolism (VTE), it is critical to balance efficacy with bleeding risk. For patients who require anticoagulation and also have renal impairment, careful risk assessment is important. Not all bleeding risk calculators include renal considerations. This tool provides those that do, with links to both online and mobile app versions.